ClinConnect ClinConnect Logo
Search / Trial NCT04814966

Feasibility of Extended Non-invasive Haemodynamic Monitoring in the PACU

Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Mar 23, 2021

Trial Information

Current as of June 25, 2025

Completed

Keywords

Goal Directed Haemodynamic Optimization Ultrasound Therapy Postoperative Complications

ClinConnect Summary

Postoperative haemodynamic management, with particular emphasis on adequate volume status, is essential for patient outcome, as is optimised intraoperative management. Postoperative monitoring is usually performed in the PACU by non-invasive, continuous and intermittent monitoring. ECG and oxygen saturation are monitored continuously, blood pressure and laboratory analyses intermittently. The assessment of adequate oxygen supply (cardiac output - haemoglobin concentration - oxygen saturation) in the PACU is traditionally approximated only by surrogate parameters such as blood pressure and h...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients with ASA classification I-III undergoing abdominal surgery, surgery in urology or vascular surgery
  • written consent
  • Exclusion Criteria:
  • Age \<18 years
  • ASA classification IV or higher
  • legal care relationship
  • missing or faulty written consent

About University Hospital Schleswig Holstein

University Hospital Schleswig-Holstein (UKSH) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution, UKSH integrates cutting-edge medical research with comprehensive patient care, fostering an environment that promotes the development of novel therapeutic strategies. With a multidisciplinary approach and a strong emphasis on collaboration, UKSH is dedicated to enhancing clinical outcomes and contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into practice.

Locations

Kiel, Deutschland (Deu), Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials